Trials / Recruiting
RecruitingNCT07082374
Dual Subsartorial Versus Adductor Canal Block Versus Femoral Nerve Block for Postoperative Analgesia in Patients Undergoing Total Knee Arthroplasty
Dual Subsartorial Block Versus Adductor Canal Block Versus Femoral Nerve Block for Postoperative Analgesia in Patients Undergoing Total Knee Arthroplasty: A Randomized Clinical Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to compare the effect of dual subsartorial block (DSB), adductor canal block (ACB), and femoral nerve block (FNB) for postoperative analgesia in patients undergoing total knee arthroplasty (TKA).
Detailed description
Total knee arthroplasty (TKA) offers increased joint mobility and painless ambulation to patients. Femoral nerve block (FNB) is commonly used to relieve postoperative pain and opioid consumption. Adductor canal block (ACB) is a common analgesic intervention for postoperative pain control following TKA. The dual subsartorial block (DSB) is a novel procedure-specific and motor-sparing regional analgesia (RA) technique that may reduce overall postoperative opioid consumption when used in conjunction with multimodal analgesia.
Conditions
- Dual Subsartorial Block
- Adductor Canal Block
- Femoral Nerve Block
- Postoperative Analgesia
- Total Knee Arthroplasty
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Dual subsartorial block | Patients will receive dual subsartorial block (DSB). |
| OTHER | Adductor canal block | Patients will receive an adductor canal block (ACB). |
| OTHER | Femoral nerve block | Patients will receive a femoral nerve block (FNB). |
Timeline
- Start date
- 2025-07-24
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2025-07-24
- Last updated
- 2025-07-25
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07082374. Inclusion in this directory is not an endorsement.